324 results match your criteria: "Institute of Pathology and Molecular Pathology[Affiliation]"
Histopathology
September 2025
Institute of Pathology and Molecular Pathology, Bundeswehrkrankenhaus Ulm, Ulm, Germany.
Background: Given that pathologists now frequently assess pathologic response following neoadjuvant or perioperative chemoimmunotherapy for NSCLC, we set up a multicentre study to evaluate the current practice of regression grading in Germany (Re-GraDE NSCLC).
Methods: 133 cases of NSCLC resection specimens following chemoimmunotherapy (IO) were collected from 9 high-volume lung cancer centres in Germany. Case characteristics were obtained from pathology reports/electronic medical records.
Swiss Med Wkly
August 2025
National Agency for Cancer Registration (NACR), Zurich, Switzerland.
Background: The COVID-19 pandemic disrupted healthcare systems worldwide. This raised concerns about delays in cancer diagnosis and treatment, with potentially worse patient outcomes. The aim of this nationwide, population-based cohort study was to investigate the impact of the COVID-19 pandemic on cancer incidence, stage distribution and one-year survival in Switzerland.
View Article and Find Full Text PDFCancer Med
July 2025
Cancer Registry Zurich, Zug, Schaffhausen and Schwyz, Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
Purpose: We aimed to analyse trends in incidence, mortality and 5-year relative survival of malignant and benign/borderline brain and central nervous system (CNS) tumours between 1980 and 2021 in the Canton of Zurich, Switzerland, stratified by sex, age group, behaviour and histological subtypes.
Methods: We used incidence data from the Cancer Registry of Zurich, Zug, Schaffhausen and Schwyz, including primary benign/borderline and malignant tumours diagnosed between 1980 and 2021 in the Canton of Zurich in patients aged ≥ 15 years (N = 10,226). Mortality data were provided by the Swiss Federal Statistical Office (N = 3514).
Am J Clin Nutr
September 2025
Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland; Cancer Registry Zurich, Zug, Schaffhausen and Schwyz, Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. Electronic
Background: Since a healthy diet is a key contributor to human health and risk of developing noncommunicable diseases, the EAT-Lancet Commission proposed the "planetary health diet" (PHD) in 2019. The literature on the association between the PHD and risk for health outcomes is sparse and diverse.
Objectives: To increase the knowledge of the potential effects of the PHD on human health, we analyzed data from a prospective cohort study, investigating whether habitual adherence to the PHD was associated with health outcomes among participants in the UK Biobank cohort study.
Clin Transl Med
July 2025
Laboratory of Haemato-oncology and Clinical Biochemistry, Hospital Havirov, Havirov, Czech Republic.
Front Cardiovasc Med
May 2025
Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Background: Patients with congenital heart disease (CHD) who are operated on after birth are at risk for neurodevelopmental (ND) impairment. Before birth, altered fetal hemodynamics due to the CHD may lead to reduced cerebral perfusion and oxygen supply. The placenta as a critical organ may enhance this pathology.
View Article and Find Full Text PDFLife Sci Alliance
August 2025
Institute of Molecular Tumor Biology, Faculty of Medicine, University Münster, Münster, Germany
κB-Ras/RalGAP complexes limit the activity of Ral GTPases, which function in EGFR/Ras signaling. RalGAP expression is down-regulated in pancreatic cancer; however, the role of RalGAP and Ral GTPases in tumor development in vivo remained unclear. Here, we show that pancreatic RalGAPβ deficiency alone is sufficient to induce inflammation and neoplasia in vivo.
View Article and Find Full Text PDFDiagn Pathol
May 2025
Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
Background: KRAS exon 2 mutations are highly prevalent in human malignancies, making them attractive targets for detection and monitoring in cell-free DNA (cfDNA) of cancer patients. Drop-off assays designed for digital polymerase chain reaction (ddPCR drop-off) span entire mutational hotspots and detect any mutated allele within the covered region, overcoming a major limitation of mutation-specific ddPCR assays. We therefore set out to develop a novel KRAS codon 12/13 ddPCR drop-off assay for the robust, highly sensitive and specific detection of KRAS exon 2 hotspot mutations in cfDNA.
View Article and Find Full Text PDFLeukemia
July 2025
Institute of Pathology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Histopathological growth patterns (GP) in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) have previously been divided into GP AB (typical) vs CDEF (variant). However, it is unclear whether this division is optimal. We thus investigated alternative GP grouping approaches (GP ABC vs DEF; GP ABCF vs DE).
View Article and Find Full Text PDFSci Rep
May 2025
Cardio-CARE, Medizincampus Davos, Herman-Burchard-Str. 12, Davos Wolfgang, 7265, Davos, Switzerland.
Efficient data compression technologies are crucial to reduce the cost of long-term storage and file transfer in whole genome sequencing studies. This study benchmarked four specialized compression tools developed for paired-end fastq.gz files DRAGEN ORA 4.
View Article and Find Full Text PDFBreast Care (Basel)
April 2025
Clinical Institute of Pathology and Molecular Pathology, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria.
Introduction: Phyllodes tumors of the breast are a very rare tumor entity. There are two different classifications according to AFIP (low-grade and high-grade phyllodes tumors of the breast) and WHO (three subtypes: benign, borderline, and malignant phyllodes tumors). Phyllodes tumors have an increased risk of recurrence.
View Article and Find Full Text PDFJ Sport Health Sci
April 2025
Amsterdam UMC, Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam 1081 HV, the Netherlands.
Eur J Cancer
May 2025
Division of Oncology, Luzerner Kantonsspital, Luzern, Switzerland.
Background: Soft tissue sarcomas (STS) and other mesenchymal tumours belong to rare, heterogeneous neoplasms with over 150 subtypes that pose significant challenges in diagnosis and clinical decision making. While guidelines address evidence-based diagnostic and therapeutic procedures, clinical situations and scenarios without evidence remain controversial in daily practice. The 2024 Conference on Challenges in Sarcoma (CCS2024) aimed to narrow these gaps with the support of an international and multidisciplinary panel of sarcoma experts.
View Article and Find Full Text PDFEndocr Pathol
March 2025
Institute of Pathology, Philipps University Marburg and University Hospital Marburg, Baldingerstrasse, Marburg, Germany.
Delta-like ligand 3 (DLL3) is frequently expressed in pulmonary small cell neuroendocrine carcinoma (SCNEC) and has emerged as a promising therapeutic target. However, limited data on DLL3 expression in other neuroendocrine neoplasms (NEN), such as extrapulmonary SCNEC, large cell neuroendocrine carcinomas (LCNEC), mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN), gastroenteropancreatic neuroendocrine tumours (GEP-NET), and pulmonary carcinoids, impedes an estimation if other types of NEN might be suitable candidates for anti-DLL3 therapies. We evaluated DLL3 expression in 1294 NEN and 479 non-neuroendocrine carcinomas, correlating the findings with histological subtypes, tumour localisation, and overall survival (OS).
View Article and Find Full Text PDFDiagnostics (Basel)
March 2025
Institute of Pathology and Molecular Pathology, Bundeswehrkrankenhaus Ulm, 89081 Ulm, Germany.
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. Advances in tissue-based biomarkers have significantly enhanced diagnostic and therapeutic approaches in NSCLC, enabling precision medicine strategies. This review provides a comprehensive analysis of the molecular pathologist's practical approach to assessing NSCLC biomarkers across various specimen types (liquid biopsy, broncho-alveolar lavage, transbronchial biopsy/endobronchial ultrasound-guided biopsy, and surgical specimen), including challenges such as biological heterogeneity and preanalytical variability.
View Article and Find Full Text PDFDevelopment
April 2025
Institute of Interdisciplinary Research in Molecular Human Biology (IRIBHM, https://iribhm.org/), Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.
Collagenase and dispase treatment of intestinal tissue from adult mice generates cells growing in matrigel as stably replatable cystic spheroids, in addition to differentiated organoids. Contrary to classical EDTA-derived organoids, these spheroids display poor intestinal differentiation and grow independently of Rspondin, noggin and EGF. Their transcriptome strikingly resembles that of fetal intestinal spheroids, with downregulation of crypt base columnar cell (CBC) markers (Lgr5, Ascl2, Smoc2 and Olfm4).
View Article and Find Full Text PDFJ Cancer Res Clin Oncol
February 2025
Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.
Purpose: Swiss healthcare institutions conducted only urgent procedures during the COVID-19 lockdown, potentially leading to a lack of care for other severe diseases, such as cancer. We examined the effects of the pandemic on cancer stage distribution and time between cancer diagnosis and treatment initiation using population-based cancer registry data.
Methods: The study was based on data of the cancer registry of the cantons of Zurich and Zug from 2018 to 2021.
Heliyon
January 2025
Department of Pneumology, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081, Ulm, Germany.
Introduction: Pulmonary post-acute COVID-19 sequelae (PASC) can occur in professional athletes. In these individuals, the physical impairment can ultimately mean the end of their career due to the lack of specific treatment strategies. Individualised treatment approaches are required, as demonstrated in this case report.
View Article and Find Full Text PDFEur Respir Rev
January 2025
Institute of Pathology, University Clinics Aachen, RWTH University of Aachen, Aachen, Germany
Interstitial lung disease (ILD) is a clinical term that refers to a diverse group of non-neoplastic lung diseases. This group includes idiopathic and secondary pulmonary entities that are often associated with progressive pulmonary fibrosis. Currently, therapeutic approaches based on specific structural targeting of pulmonary fibrosis are limited to nintedanib and pirfenidone, which can only slow down disease progression leading to a lower mortality rate.
View Article and Find Full Text PDFNat Biotechnol
December 2024
Department of Surgery, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Clin Nutr
January 2025
The Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Northern Ireland, UK; Medical University of Vienna, Center for Public Health, Public Health Nutrition, Vienna, Austria; University of Vienna, Department of Nutritional Sciences, Vienna, Austria. Electr
J Eur Acad Dermatol Venereol
May 2025
Department of Dermatology and Venereology, Kepler University Hospital Linz, Linz, Austria.
Darier disease is a rare autosomal dominant genodermatosis caused by mutations in the ATP2A2 gene encoding for sarcoendoplasmic reticulum Ca ATPase isoform 2. The skin disease is characterized by a chronic relapsing course with recurrent reddish-brown keratotic papules and plaques located mainly in seborrhoeic areas. Due to chronic inflammation and epidermal barrier defects of the skin, patients often develop severe bacterial and viral superinfections.
View Article and Find Full Text PDFCancers (Basel)
October 2024
Division of Chronic Disease Epidemiology, Department of Epidemiology, Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, 8001 Zurich, Switzerland.
This study aims to investigate differences in cancer diagnosis based on absolute case numbers and age-standardized incidence rate ratios (IRRs) in the pre-Coronavirus disease 2019 (COVID-19) years (2018/19) and the first two years of the COVID-19 pandemic (2020, 2021) in two Swiss cantons. : Data of the Swiss cantonal cancer registry of the cantons of Zurich (ZH) and Zug (ZG) were used to descriptively investigate differences in annual and monthly absolute numbers regarding all-cancer and the five most common cancer types. Directly age-standardized monthly incidence rates (IRs) were calculated.
View Article and Find Full Text PDFSci Rep
October 2024
Institute of Neuropathology, Justus-Liebig University, Giessen, Germany.
To gain a deeper understanding of skeletal muscle function in younger age and aging in elderly, identification of molecular signatures regulating these functions under physiological conditions is needed. Although molecular studies of healthy muscle have been conducted on adults and older subjects, there is a lack of research on infant muscle in terms of combined morphological, transcriptomic and proteomic profiles. To address this gap of knowledge, we performed RNA sequencing (RNA-seq), tandem mass spectrometry (LC-MS/MS), morphometric analysis and assays for mitochondrial maintenance in skeletal muscle biopsies from both, infants aged 4-28 months and adults aged 19-65 years.
View Article and Find Full Text PDFNat Commun
September 2024
Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Recent single-cell transcriptomes revealed spatiotemporal programmes of liver function on the sublobular scale. However, how sexual dimorphism affected this space-time logic remained poorly understood. We addressed this by performing scRNA-seq in the mouse liver, which revealed that sex, space and time together markedly influence xenobiotic detoxification and lipoprotein metabolism.
View Article and Find Full Text PDF